Vol. 9 No. 4 (2021) | ADMET and DMPK

Vol. 9 No. 4 (2021)

New Therapeutic Modalities in Drug Discovery and Development: Insights & Opportunities

Special issue guest-edited by Manfred Kansy and Giulia Caron

Published: 15-12-2021

Editorial

New therapeutic modalities in drug discovery and development: Insights & opportunities

Manfred Kansy, Giulia Caron

ADMET and DMPK, Vol. 9 No. 4 (2021), 227-230

Published 15-12-2021;

DOI: https://doi.org/10.5599/admet.1209
- PDF

Reviews

Current state and future of 3D bioprinted models for cardio-vascular research and drug development

Liudmila Polonchuk, Carmine Gentile

ADMET and DMPK, Vol. 9 No. 4 (2021), 231-242

Published 25-08-2021;

DOI: https://doi.org/10.5599/admet.951
- PDF

Original Scientific Articles

Are we ready to design oral PROTACs®?

Diego Garcia Jimenez, Matteo Rossi Sebastiano, Giulia Caron, Giuseppe Ermondi

ADMET and DMPK, Vol. 9 No. 4 (2021), 243-254

Published 31-08-2021;

DOI: https://doi.org/10.5599/admet.1037
- PDF
- Supplementary material
Synthesis of silymarin−selenium nanoparticle conjugate and examination of its biological activity in vitro

Sergey Staroverov, Sergey Kozlov, Alexander Fomin, Konstantin Gabalov, Vitaliy Khanadeev, Dmitry Soldatov, Ivan Domnitsky, Lev Dykman, Sergey V. Akchurin, Olga Guliy

ADMET and DMPK, Vol. 9 No. 4 (2021), 255-266

Published 14-11-2021;

DOI: https://doi.org/10.5599/admet.1023
- PDF
cΔlog kwIAM: can we afford estimation of small molecules’ blood-brain barrier passage based upon in silico phospholipophilicity?

Lucia Grumetto, Giacomo Russo

ADMET and DMPK, Vol. 9 No. 4 (2021), 267-281

Published 15-12-2021;

DOI: https://doi.org/10.5599/admet.1034
- PDF
- Supplementary data